TrackPaw Scientific just raised €2.3M to fix a €11B problem.

Swedish startup closed a €2.3M seed round co-led by FSG Fund II and Industrifonden. They're building AI-powered monitoring tools for preclinical research.

Key metrics:
• €2.3M seed + €0.5M from existing shareholders
• Founded 2022, targeting €11B+ global market by 2030
• 90% of clinical trials fail due to inconsistent preclinical data
• Commercial launch planned for Nordics in H2 2026

The problem: Over 90% of clinical development failures stem from subjective animal studies. TrackPaw uses ML + sensors for 24/7 objective monitoring.

Why it matters: Better preclinical data = fewer failed trials = faster drug development.

Source: BeBeez International

#startups #biotech